Merck, 98042014-1VL, B1D6

Immunogen
Human placenta FcR
Application
FcR studies
Biochem/physiol Actions
Not specified
The hybridoma B1D6 was obtained by immunising BALB/c mice with human placental extract followed by intravenous injections with purified Fc gamma-receptor (receptor for the Fc portion of immunoglobulins, FcR). Spleen cells were then fused with the myeloma P3X63Ag8 to establish B1D6 secreting IgG1, kappa, monoclonal antibodies. This antibody has been shown to stain FcR-positive areas in sections of placental tissues, inhibited the haemadsorption of placental tissue of erythrocytes sensitised with IgG antibodies and the agglutination of these erythrocytes by FcR.
Preparation Note
Maintain cultures between 3-9 x 100,000 cells/ml; 5% CO₂; 37 °C
RPMI 1640 + 2 mM glutamine + 10% FBS
Other Notes
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). Genomic DNA is not available for this cell line. Use of this product by commercial organizations may require a license agreement. Commercial organizations will be contacted by [email protected] to provide further information after the order request is submitted. Any other use of this cell line is prohibited without the express written permission of UKHSA. Inquiries regarding any other authorized use of this cell line may be directed to [email protected].